H.R.601 – Medical Cannabis Research Act of 2019 116th Congress (2019-2020) |
|Sponsor:||Rep. Gaetz, Matt [R-FL-1] (Introduced 01/16/2019)|
|Committees:||House – Energy and Commerce; Judiciary; Veterans’ Affairs|
|Latest Action:||House – 03/04/2019 Referred to the Subcommittee on Crime, Terrorism, and Homeland Security. (All Actions)|
This bill has the status Introduced
Here are the steps for Status of Legislation:
- Constitutional Authority Statement
- CBO Cost Estimates 
Subject — Policy Area:
- View subjects
Summary: H.R.601 — 116th Congress (2019-2020) All Information (Except Text)
There is one summary for H.R.601. Bill summaries are authored by CRS.
Introduced in House (01/16/2019)
Medical Cannabis Research Act of 2019
This bill establishes a new, separate registration process for manufacturers of cannabis for research.
As a part of this process, the Drug Enforcement Administration must annually assess whether there is an adequate and uninterrupted supply of research cannabis and register additional manufacturers.
The bill also authorizes health care providers of the Department of Veterans Affairs to provide information to veterans regarding participation in federally approved cannabis clinical trials.Summary of H.R.601 – 116th Congress (2019-2020): Medical Cannabis Research Act of 2019 ]]>